Texas Yale Capital Corp. - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 122 filers reported holding HOMOLOGY MEDICINES INC in Q4 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Texas Yale Capital Corp. ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q3 2023$11,700
+32.2%
10,0000.0%0.00%
Q2 2023$8,850
-14.1%
10,0000.0%0.00%
-100.0%
Q1 2023$10,300
-18.3%
10,0000.0%0.00%0.0%
Q4 2022$12,600
-21.2%
10,0000.0%0.00%0.0%
Q3 2022$16,000
-20.0%
10,0000.0%0.00%0.0%
Q2 2022$20,000
-33.3%
10,0000.0%0.00%
-50.0%
Q1 2022$30,000
-16.7%
10,0000.0%0.00%0.0%
Q4 2021$36,000
-54.4%
10,0000.0%0.00%
-50.0%
Q3 2021$79,000
+8.2%
10,0000.0%0.00%0.0%
Q2 2021$73,000
-22.3%
10,0000.0%0.00%
-33.3%
Q1 2021$94,00010,0000.01%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q4 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$16,511,0003.10%
Vida Ventures Advisors, LLC 770,845$2,806,0001.05%
Vivo Capital, LLC 853,143$3,105,0000.19%
AAF Wealth Management, LLC 47,501$173,0000.12%
OUP Management Co., LLC 64,000$233,0000.10%
GSA CAPITAL PARTNERS LLP 195,596$712,0000.09%
Temasek Holdings (Private) Ltd 5,650,996$20,570,0000.07%
Bellevue Group AG 1,737,122$6,323,0000.06%
XTX Topco Ltd 26,212$95,0000.05%
Virtus ETF Advisers LLC 37,588$137,0000.05%
View complete list of HOMOLOGY MEDICINES INC shareholders